Sun Pharmaceutical Industries Ltd Says U.S. Court Denies Motion on Protonix

Reuters -- Sun Pharmaceutical said a U.S. court had denied its motion to reverse a jury verdict of infringement against the Indian firm on Pfizer's Protonix acid reflux drug patent that the jury had said was valid.

Back to news